BackEcho Therapeutics Overview

Echo Therapeutics Selling, General & Admin

See how ECTE's SG&A expenses trends over time vs similar companies.

Get informed when a big investor buys or sells

+ Follow

Quarterly SG&A Expenses

$1.23M
57.44% YoY

As of Sep 30, 2016

Annual SG&A Expenses (TTM)

$3.79M
39.62% YoY

Trailing 12 months ending Sep 30, 2016

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Echo Therapeutics (ECTE) FAQ

Stockcircle tracks selling, general & admin for Echo Therapeutics (ECTE), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Selling, General & Admin page is built for Echo Therapeutics's historical SG&A expenses trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use SG&A expenses as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main ECTE overview so you can move from this figure to the surrounding analysis quickly.